T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.17% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
LyondellBasell Industries
LYB
$20.2B
| $29.4M | ﹤0.01% |
336,228
-35,427
| -10% | -$3.69M |
|
1052
Crocs
CROX
$6.36B
| $29.4M | ﹤0.01% |
603,860
-233,216
| -28% | -$14.2M |
|
1053
Willis Towers Watson
WTW
$31B
| $29.4M | ﹤0.01% |
148,778
-423,734
| -74% | -$90.8M |
|
1054
Portland General Electric
POR
$5.92B
| $29.3M | ﹤0.01% |
606,275
-785,958
| -56% | -$39.1M |
|
|
PSPC.U
1055
DELISTED
Post Holdings Partnering Corporation Units, each consisting of one share of Series A common stock, and one-third of one redeemable warrant
PSPC.U
| $29M | ﹤0.01% |
2,965,837
+13,461
| +0.5% | +$133K |
|
1056
Tenable Holdings
TENB
$4.41B
| $28.9M | ﹤0.01% |
637,287
+603,250
| +1,772% | +$31.1M |
|
|
GTLS
1057
DELISTED
Chart Industries
GTLS
| $28.8M | ﹤0.01% |
171,772
-191,646
| -53% | -$32.7M |
|
1058
CarMax
KMX
$8.52B
| $28.5M | ﹤0.01% |
315,243
-89,646
| -22% | -$8.43M |
|
1059
Ingevity
NGVT
$2.59B
| $28.5M | ﹤0.01% |
451,736
+824
| +0.2% | +$53.7K |
|
1060
SEACOR Marine Holdings
SMHI
$262M
| $28.4M | ﹤0.01% |
4,937,974
+97,862
| +2% | +$774K |
|
1061
Flowserve
FLS
$10.3B
| $28.4M | ﹤0.01% |
991,002
-10,430
| -1% | -$332K |
|
|
ABMD
1062
PUT
DELISTED
Abiomed Inc
ABMD
| $28.3M | ﹤0.01% |
+1,398,500
| New | +$377M |
|
1063
Arch Capital
ACGL
$33.5B
| $28.2M | ﹤0.01% |
620,232
-6,291
| -1% | -$292K |
|
|
BCPC
1064
Balchem Corp
BCPC
$5.65B
| $28.2M | ﹤0.01% |
217,334
+4,959
| +2% | +$621K |
|
1065
Southern First Bancshares
SFST
$612M
| $28.2M | ﹤0.01% |
645,858
+25,449
| +4% | +$1.16M |
|
1066
Ziff Davis
ZD
$1.92B
| $28.1M | ﹤0.01% |
377,588
+33,912
| +10% | +$2.81M |
|
1067
Woodward
WWD
$21.2B
| $27.8M | ﹤0.01% |
301,032
-28,799
| -9% | -$3M |
|
1068
Rapid7
RPD
$929M
| $27.7M | ﹤0.01% |
415,287
-15,671
| -4% | -$1.29M |
|
1069
Cencora
COR
$59.2B
| $27.7M | ﹤0.01% |
195,887
-19,485
| -9% | -$2.98M |
|
1070
Knowles
KN
$3.23B
| $27.6M | ﹤0.01% |
1,594,041
+1,505,412
| +1,699% | +$28.3M |
|
1071
D.R. Horton
DHI
$41.9B
| $27.6M | ﹤0.01% |
416,566
-47,519
| -10% | -$3.34M |
|
|
SPNS
1072
DELISTED
Sapiens International
SPNS
| $27.5M | ﹤0.01% |
1,135,189
+11,813
| +1% | +$285K |
|
1073
Sun Communities
SUI
$14.6B
| $27.5M | ﹤0.01% |
172,308
-56,482
| -25% | -$9.48M |
|
|
SGI
1074
Somnigroup International
SGI
$14B
| $27.3M | ﹤0.01% |
1,276,113
-800,401
| -39% | -$20.6M |
|
|
MORF
1075
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $27.1M | ﹤0.01% |
1,248,560
+135,909
| +12% | +$3.79M |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.